HENDERSON, Nev. — Leading Edge Pharms announced Tuesday that Steve Armstrong has been appointed vice president of sales. Armstrong will drive sales efforts of Leading Edge’s CANNAVERA range of topical pain and inflammation solutions based on hemp-derived cannabinoids, including CBD, to wholesalers and retailers across the United States and global markets. Armstrong will also lead sales
HENDERSON, Nevada — Leading Edge Pharms has announced a distribution deal with MarketHub Retail Services, a distribution network focusing on hemp-based health products. The deal provides MarketHub with rights to distribute Leading Edge’s line of Cannavera Pain Relief products with major retailers nationwide. “MarketHub has set a high standard of quality for the hemp products
HENDERSON, Nev. — Leading Edge Pharms, a biotechnology company developing novel cannabinoid therapies and innovative delivery platforms, Wednesday announced its partnership with Independent Pharmacy Alliance (IPA), a trade group and retail pharmacy buying cooperative, to make LEP’s Hemp/CBD-based Cannavera Topical Pain Relief products available to IPA’s 3,100 member pharmacies, located in New York, New Jersey,
HENDERSON, Nev. — Leading Edge Pharms, a biotechnology company developing novel cannabinoid therapies and innovative delivery systems, announced the launch of a new pain relief ointment in their existing Cannavera product line of topical pain relief creams, sprays and oils. The new pain relief ointment is strengthened with nano-encapsulated Silvidiol, a patent-pending proprietary compound of liposomal
HENDERSON, Nev. — CARE Pharmacies Cooperative Inc. (CARE), a growing independent retail drug chain serving local communities throughout the United States, and Leading Edge Pharms, Inc. (Leading Edge), a biotechnology company developing novel cannabinoid therapies and innovative delivery platforms, announced today a preferred provider relationship for Leading Edge to provide Cannavera Topical Pain Relief products to CARE